← Back to Search

HIV Self-testing for Human Immunodeficiency Virus Infection

N/A
Waitlist Available
Led By Carmen Logie, PhD
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up time 1 (month 0), time 2 (month 3)
Awards & highlights

Study Summary

This trial is testing whether or not a comic book can help improve linkage to care with HIVST for adolescents and young people in Bidi Bidi who have been displaced or are refugees.

Eligible Conditions
  • Human Immunodeficiency Virus Infection
  • Knowledge, Attitudes, and Practices (KAP)
  • HIV/AIDS

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time 1 (month 0), time 2 (month 3)
This trial's timeline: 3 weeks for screening, Varies for treatment, and time 1 (month 0), time 2 (month 3) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in HIV testing frequency
HIV status knowledge
Secondary outcome measures
Adolescent sexual and reproductive health stigma
Change in HIV knowledge
Change in HIV-related stigma
+7 more

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: HIV self-testing + educational comic bookExperimental Treatment2 Interventions
At the first visit participants will receive a HIVST kit and a detailed description of how to use the HIVST kits, pictorial and written guide for HIVST kits, in addition to contact information for confirmatory testing and linkage to care at local clinics. Participants will also receive an educational comic book focused on HIV testing information and decision making that was developed with qualitative data collected from an earlier study phase. PNs will meet with small groups of participants to read through and discuss the comic book together.
Group II: Standard of CareActive Control1 Intervention
PNs will provide information about HIV testing, care and support services at local clinics.
Group III: HIV self-testingActive Control1 Intervention
At the first visit participants will receive a HIVST kit and a detailed description of how to use the HIVST kits, pictorial and written guide for HIVST kits, in addition to contact information for confirmatory testing and linkage to care at local clinics.
Group IV: Educational comic bookActive Control1 Intervention
Participants will receive an educational comic book focused on HIV testing information and decision making that was developed with qualitative data collected from an earlier study phase. PNs will meet with small groups of participants to read through and discuss the comic book together.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HIV Self-testing
2016
N/A
~200

Find a Location

Who is running the clinical trial?

University of TorontoLead Sponsor
689 Previous Clinical Trials
1,018,523 Total Patients Enrolled
ViiV HealthcareIndustry Sponsor
359 Previous Clinical Trials
468,423 Total Patients Enrolled
Carmen Logie, PhDPrincipal InvestigatorUniversity of Toronto
5 Previous Clinical Trials
1,133 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
~42 spots leftby Apr 2025